Is a Digital Pill the Future of Medicine?
Otsuka Holdings has won FDA approval for a version of its commonly prescribed Abilify that includes a digestible sensor made by Proteus. The first-of-its-kind approval will allow patients who are taking Abilify for schizophrenia or bipolar disorder to share information the sensor collects with their healthcare provider through a wearable patch and a smartphone application. Is this going to change outcomes for these patients?
In this clip from The Motley Fool's Industry Focus: Healthcare, contributor Todd Campbell joins Kristine Harjes to discuss the implications of this digital pill.
A full transcript follows the video.
Source: Fool.com
